Manager TitleAgeSince
Compliance Officer 70 2015-02-28
Chief Tech/Sci/R&D Officer 63 2001-12-31
Date Insider Type Main position Quantity % Market Cap.
10/29/21 Issuer sale

Director

20,000 0.1148%
10/29/21 Issuer sale

Director

1,744,017 10.0087%
10/29/21 Issuer sale

Responsable ventes & marketing

319,443 1.8332%
Change 5-day change 1-year change 3-year change Capi.($)
+4.74%+2.95% - - 463M
+0.44%-0.53%+36.21%+5.04% 12.45B
-1.76%+10.89%+21.35%+19.35% 6.55B
-0.53%-1.99%+51.79%+21.11% 5.56B
0.00%+2.83% - - 4.59B
+2.14%+0.83%-27.36%+22.99% 4.38B
-1.76%-0.33%-22.06%-21.97% 4.11B
+28.39%+21.74%+21.08%-47.85% 1.8B
0.00%-6.35%-13.24%+219.26% 1.73B
+0.33%-0.33%+60.10%-3.17% 1.55B
Average +3.36%+1.44%+15.98%+26.84% 4.75B
Weighted average by Cap. +1.16%+2.57%+20.36%+15.85%
Logo Misonix, Inc.
Misonix, Inc. (Misonix), is a medical devices company. The Company is engaged in designing, manufacturing and marketing of minimally invasive therapeutic ultrasonic medical devices. Its products include BoneScalpel Surgical System (BoneScalpel), SonicOne Wound Cleansing and Debridement System (SonicOne) and SonaStar Surgical Aspirator (SonaStar). BoneScalpel is used for surgical procedures involving the precise cutting and sculpting of bone while sparing soft tissue. SonaStar is used to emulsify and remove soft and hard tumors, primarily in the neuro and general surgery field. SonicOne offers tissue specific debridement and cleansing of wounds and burns for effective removal of devitalized tissue and fibrin deposits while sparing viable cells. The Company's products are nexus, BoneScalpel, SonaStar, SonicOne, TheraSkin and Therion.
Employees
281
  1. Stock Market
  2. Stocks
  3. MSON Stock